Quantcast

Latest Neuroprosthetics Stories

2014-06-25 12:41:00

Cedars-Sinai Medical Center Study led by Cedars-Sinai researchers uses computer modeling software to calculate target and programming details Although deep brain stimulation can be an effective therapy for dystonia – a potentially crippling movement disorder – the treatment isn't always effective, or benefits may not be immediate. Precise placement of DBS electrodes is one of several factors that can affect results, but few studies have attempted to identify the "sweet spot," where...

2014-06-24 12:28:49

Dr. Michael Bennett Only Private Sector Surgeon Selected Nationwide HONOLULU, June 24, 2014 /PRNewswire/ -- Dr. Michael Bennett MD, FACS, founder of The Retina Institute of Hawaii, has been named one of thirteen prestigious surgeons across the United States to conduct the procedure for the Argus® II Retinal Prosthesis System. The Argus II (also called the "bionic eye") is an implantable visual prosthetic and was selected in 2013 CNN's Top 10, Time Magazine's Best Inventions and in...

2014-06-23 23:10:58

In cooperation with the SME Education Foundation, Curbell Donation Assists Student Project Orchard Park, NY (PRWEB) June 23, 2014 Curbell Plastics, Inc., one of the nation’s premier suppliers of plastic sheet, rod, tube, film, adhesives, sealants and prototyping materials, recently donated $18,000 of plastic that will be used by Alabama High School students to create lightweight, removable prosthetic limbs for amputees in Honduras. The project is a joint venture of the SME Education...

Self-powered Artificial Cardiac Pacemaker Developed By Researchers
2014-06-23 03:49:58

The Korea Advanced Institute of Science and Technology (KAIST) As the number of pacemakers implanted each year reaches into the millions worldwide, improving the lifespan of pacemaker batteries has been of great concern for developers and manufacturers. Currently, pacemaker batteries last seven years on average, requiring frequent replacements, which may pose patients to a potential risk involved in medical procedures. A research team from the Korea Advanced Institute of Science and...

2014-06-23 04:20:48

Retina Implant AG's Lead Clinical Trial Investigator Presents Patient Experiences with the Alpha IMS Subretinal Implant LONDON, June 23, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany,...

2014-06-11 20:22:38

Data Presented at the 18th International Congress of Parkinson's Disease and Movement Disorders Demonstrate Highly Significant Improvement in Motor Function for Patients with Parkinson's Disease NATICK, Mass., June 11, 2014 /PRNewswire/ -- Patients with Parkinson's disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System demonstrated a highly significant and consistent improvement in motor scores, according to the latest one-year...

2014-06-10 20:23:03

Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease NATICK, Mass., June 10, 2014 /PRNewswire/ -- A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease (PD). The CUSTOM-DBS clinical study demonstrated that shorter...

2014-06-08 23:01:31

United States Cardiovascular Procedures Market Forecast to 2020 in New Research Report Available at RnRMarketResearch.com Dallas, Texas (PRWEB) June 08, 2014 “United States Cardiovascular Procedures Outlook to 2020″, provides key procedures data on the United States Cardiovascular Procedures. The report provides procedure volumes within market categories – Cardiac Assist Procedures, Cardiovascular Surgery, Electrophysiology Procedures, Cardiac Rhythm Management (CRM) Procedures,...

2014-06-04 14:55:45

The JAMA Network Journals An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA. Although clinical trials have established the ICD as the best currently available therapy to prevent sudden...

2014-06-04 14:50:47

Duke University Medical Center Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute. The findings, published in the June 4 issue of the Journal of the American Medical Association, support existing recommendations to implant ICDs in patients with a left ventricular...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'